$46.0 Million
Eiger BioPharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$38.0 Million
Novan, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$37.4 Million
Ocular Therapeutix, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$57.5 Million
Catalyst Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$250.0 Million
Prothena Corporation plc
At the Market Offering
Left Bookrunner
$45.0 Million
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
$125.0 Million
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
$175.0 Million
Fulgent Genetics, Inc.
At the Market Offering
Left Bookrunner
$30.0 Million
Fulgent Genetics, Inc.
Follow-On Offering
Left Bookrunner
$252.0 Million
Solo Brands
Initial Public Offering
Left Bookrunner
Subscribe to Left Bookrunner

© 2024 Piper Sandler Companies. Since 1895. All rights reserved.